ArticleJournal of diabetes research2026
Mechanism of Platelet-Rich Plasma in Promoting Diabetic Wound Healing via the PI3K/AKT Signaling Pathway to Regulate Collagen Synthesis and Angiogenesis.
Article in Journal of diabetes research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Wound Healing Potential of Multifunctional Nanomaterials: Mechanism, Future Prospects, and Challenges.Pharmaceutics · 2026Review
- Review
- Mechanism of Platelet-Rich Plasma in Promoting Diabetic Wound Healing via the PI3K/AKT Signaling Pathway to Regulate Collagen Synthesis and Angiogenesis.Journal of diabetes research · 2026Article
- Platelet-rich therapies in cutaneous and mucocutaneous disorders characterized by inflammatory tissue responses: mechanistic insights and clinical evidence.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Platelet-rich plasma (PRP) has been found effective in wound healing, yet the underlying mechanisms in the healing of diabetic wounds remain unclear. In this study, we focus on investigating the role of PRP in enhancing the wound healing in a diabetic mouse model, specially through the modulation of the PI3K/AKT signaling pathway and its effect on collagen production and angiogenesis in the wounds of diabetic mouse model. In our in vitro experiments, we observed that PRP, in a concentration-dependent manner, significantly stimulated the proliferation, migration, and collagen synthesis in human dermal fibroblasts. Concurrently, PRP activated the PI3K/AKT and TGF-β/SMAD2 signaling pathways. In vivo, utilizing a diabetic mouse model of wound healing, PRP treatment significantly enhanced wound healing by accelerating wound closure, improving collagen deposition and organization, and promoting angiogenesis, as evidenced by increased expression of CD31 and VEGF. Importantly, the application of the PI3K inhibitor LY294002 effectively inhibited the observed effects of PRP. Additionally, the activation of the TGF-β/SMAD2 signaling pathway induced by PRP was also suppressed when PI3K was inhibited, suggesting that the PI3K/AKT pathway functions upstream to regulate TGF-β/SMAD2 signaling. These findings elucidate the role of PRP in facilitating diabetic wound healing through the activation of the PI3K/AKT pathway, which subsequently cross-regulates TGF-β/SMAD2 signaling, thereby enhancing cellular functions vital for tissue regeneration. Our results contribute valuable mechanistic insights into the therapeutic potential of PRP in addressing impaired wound healing in diabetic patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.